Bluejay Diagnostics Inc (BJDX) — Strategic Asset Allocation Index
Bluejay Diagnostics Inc (BJDX) has a Strategic Asset Allocation Index of 14.7% as of December 2022. Strategic assets (PP&E of $1.70 Million plus long-term investments of $-) total $1.70 Million, measured against net assets of $11.54 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base.
SAAI
Strategic Assets
PP&E
Net Assets
Bluejay Diagnostics Inc Strategic Asset Allocation Index (2021–2022)
This chart shows how Bluejay Diagnostics Inc's Strategic Asset Allocation Index has evolved across 2 annual periods from 2021 to 2022. As of December 2022, the index stands at 14.7%, representing strategic assets of $1.70 Million against net assets of $11.54 Million USD. Explore BJDX cash generation efficiency to assess how effectively this company generates cash.
Annual Strategic Asset Allocation Index for Bluejay Diagnostics Inc (2021–2022)
The table below presents the year-by-year Strategic Asset Allocation Index for Bluejay Diagnostics Inc from 2021 to 2022, covering 2 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see Bluejay Diagnostics Inc stock valuation.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 14.7% | $1.70 Million | $1.70 Million | $- | $11.54 Million | ▲ +13.1 pp |
| 2021 | 1.7% | $337.37K | $337.37K | $- | $20.38 Million | — |